| AEREA Y POSTAL EX-IAAC | 2023 | 20 | KG | 17a-ethynyl-17ßhydroxyandrost-4-en-[2,3-d]isoxazole S/M S/M 17a-ethynyl-17ßhydroxyandrost-4-en-[2,3-d]isoxazole MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 11190 |
| AEREA Y POSTAL EX-IAAC | 2023 | 25 | KG | 11+,17, 21-TRIHYDROXY-6+-METHYLPREGNA-1,4-DIENE-3,20-DIONE-21-SODIUM SUCCINATE, S/M, S/M 11+,17, 21-TRIHYDROXY-6+-METHYLPREGNA-1,4-DIENE-3,20-DIONE-21-SODIUM SUCCINATE MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOS | ITALY | ITALY | 38260 |
| AEREA Y POSTAL EX-IAAC | 2023 | 0.091 | KG | LIOTIRONINA (USP), USP, S/M LIOTHYRONINE (250 MG) ESTANDAR PARA ANALISIS EN EL LABORATORIO PRESENTACION: 1 VIAL X 250 MG, CODIGO: 1368008, LOTE: R15820 | INDIA | UNITED STATES | 256.02 |
| MARITIMA DEL CALLAO | 2023 | 300 | KG | 1,3,7-TRIMETHYL-2,7-DIHYDRO-1H S/M S/M 1,3,7-TRIMETHYL-2,7-DIHYDRO-1H-PURINE-2,6-DIONE MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | GERMANY | 5225 |
| AEREA Y POSTAL EX-IAAC | 2023 | 0.001 | KG | CAFEINA SISTEMA DE ADECUACION S/M S/M Caffeine for system suitability CRS ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO PRESENTACION: 2 VIALES DE 10MG C/U LOTE: L07.00 COD: Y0000787 | FRANCE | FRANCE | 171.75 |
| AEREA Y POSTAL EX-IAAC | 2023 | 6 | KG | 1r,2r,4s,5s,7s,9r)-9-butyl-7-(((2s)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azon 1r,2r,4s,5s,7s,9r)-9-butyl-7-(((2s)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azon MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KIL | AUSTRALIA | GERMANY | 6939.21 |
| AEREA Y POSTAL EX-IAAC | 2023 | 7 | KG | 1R, 2R, 4S, 5S,7S,9R)-9-BUTYL-7-(((2S)-3-HYDROXY-2-PHENYLPROPANOYL)-9-, S/M, S/M 1R, 2R, 4S, 5S,7S,9R)-9-BUTYL-7-(((2S)-3-HYDROXY-2-PHENYLPROPANOYL)-9-METHYL-3-OXA-9- AZONIATRICYCLO(3.3.1.02,4)NONANE BROMIDE MATERIA PRIMA PARA FABRICACION DE MEDICAME | AUSTRALIA | GERMANY | 8433.11 |
| AEREA Y POSTAL EX-IAAC | 2023 | 32 | KG | 1R, 2R,4S,5S,7S,9r)-9-Butyl-7-(((2s)-3-hydroxy-2-, S/M, S/M 1R, 2R,4S,5S,7S,9r)-9-Butyl-7-(((2s)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azo MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | AUSTRALIA | GERMANY | 38685 |
| AEREA Y POSTAL EX-IAAC | 2023 | 0.125 | KG | HIOSCINA BUTILBROMURO PARA SISTEMA DE ADECUACION (EP) S/M S/M HYOSCINE BUTYLBROMIDE FOR SYSTEM SUITABILITY CRS ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 1 VIAL(S) PER SALES UNIT ; 10 MG PER VIAL, LOTE: L01.00 | FRANCE | FRANCE | 92.56 |
| AEREA Y POSTAL EX-IAAC | 2023 | 1 | KG | N-[(7S)-1,2,3,1 0-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[aJheptalen-7-yl]acetamide, S/M, N-[(7S)-1,2,3,1 0-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[aJheptalen-7-yl]acetamide MATERIA PRIMA PARA PREPARACION PARA MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 9850 |
| AEREA Y POSTAL EX-IAAC | 2023 | 1 | KG | N-[( 7 S)-1,2 3, 10-tetramethox y-9-oxo- 6,7dihydro-5H-benzo[a] heptalen-7- yl ]acetamide, N-[( 7 S)-1,2 3, 10-tetramethox y-9-oxo- 6,7dihydro-5H-benzo[a] heptalen-7- yl ]acetamide MATERIA PRIMA PARA PREPARACION PARA MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 9850 |
| MARITIMA DEL CALLAO | 2023 | 20000 | KG | 4-O-B-D-GALACTOPYRANOSYL-D-FRUCTOSE S/M S/M 4-O-B-D-GALACTOPYRANOSYL-D-FRUCTOSE / LACTULOSE CONCENTRATE UPS 1250 KG MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS | AUSTRIA | GERMANY | 51430.9 |